I. Sari Et Al. , "Ga-67 uptake: A predictor of post-therapy active residual disease and clinical outcome in patients with diffuse large cell lymphoma," Erciyes Tip Dergisi , vol.30, no.1, pp.8-13, 2008
Sari, I. Et Al. 2008. Ga-67 uptake: A predictor of post-therapy active residual disease and clinical outcome in patients with diffuse large cell lymphoma. Erciyes Tip Dergisi , vol.30, no.1 , 8-13.
Sari, I., KULA, M., ESER, B., KAYNAR, L., Altuntaş, F., KOÇYİĞİT, I., ... Mavili, E.(2008). Ga-67 uptake: A predictor of post-therapy active residual disease and clinical outcome in patients with diffuse large cell lymphoma. Erciyes Tip Dergisi , vol.30, no.1, 8-13.
Sari, Ismail Et Al. "Ga-67 uptake: A predictor of post-therapy active residual disease and clinical outcome in patients with diffuse large cell lymphoma," Erciyes Tip Dergisi , vol.30, no.1, 8-13, 2008
Sari, Ismail Et Al. "Ga-67 uptake: A predictor of post-therapy active residual disease and clinical outcome in patients with diffuse large cell lymphoma." Erciyes Tip Dergisi , vol.30, no.1, pp.8-13, 2008
Sari, I. Et Al. (2008) . "Ga-67 uptake: A predictor of post-therapy active residual disease and clinical outcome in patients with diffuse large cell lymphoma." Erciyes Tip Dergisi , vol.30, no.1, pp.8-13.
@article{article, author={Ismail Sari Et Al. }, title={Ga-67 uptake: A predictor of post-therapy active residual disease and clinical outcome in patients with diffuse large cell lymphoma}, journal={Erciyes Tip Dergisi}, year=2008, pages={8-13} }